Skip to main content

Table 3 The results of network meta-analysis for MBS freedom at 2  h

From: Comparison of effectiveness and safety of lasmiditan and CGRP-antagonists for the acute treatment of migraine in adults: systematic review and network meta-analysis of randomised trials

  1. All effect sizes were presented using RRs values and 95% confidence intervals. In each column, each effect size was the result of that intervention compared to any other intervention. Cells in bold print indicate significant results